Jia Ruan

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma

Peter Martin, Amy Chadburn, Paul J. Christos et al. · Journal of Clinical Oncology · 2009 · 339 citations

Medicine, Oncology, Chemotherapy +11

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

Jia Ruan, Peter Martin, Richard R. Furman et al. · Journal of Clinical Oncology · 2010 · 319 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Postibrutinib outcomes in patients with mantle cell lymphoma

Peter Martin, Kami J. Maddocks, John P. Leonard et al. · Blood · 2016 · 283 citations · Full text

Medicine, Hematology, Oncology +8

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

Jia Ruan, Peter Martin, Bijal Shah et al. · New England Journal of Medicine · 2015 · 236 citations · Full text

Medicine, Oncology, Pharmacotherapy +16